NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Axcelead, Inc.

Axcelead, Inc.

Private
TokyoHealthcare & Life Scienceshttps://axcelead-hd.com/

Last Round

Corporate Funding

Apr 1, 2019

Company Overview

Axcelead, Inc. is a healthcare platform company that provides integrated drug discovery solutions through its subsidiary, Axcelead Drug Discovery Partners, Inc.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

contract research organizationCROdrug discoverypreclinical researchAI drug discoveryin-silico drug designhigh throughput screeningHTSmedicinal chemistryADMEsafety assessmentbioinformaticsDMTA cycleslab-in-the-looppharma R&D outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Axcelead, Inc. Comparables

Compare Axcelead, Inc. with similar companies based on industry and business-model similarity.

Axcelead, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sygnature Discovery
81%
SMC Laboratories, Inc.
80%
Selvita
77%

Axcelead, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingApr 1, 2019

Key People

Founding team and executive leadership

Yoshinori Ikeura

Representative Director, President & CEO

Executive Team

Maekawa Hiroki

代表取締役CFO

Executive Team

Axcelead, Inc. Investors

Notable investors and investment history

Axcelead, Inc. investors
InvestorRounds
WHIZ Partners, Inc.Corporate Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 28, 2024

    Grew 50% QoQ, from 12 to 18 employees.

  • Apr 1, 2019

    Led by WHIZ Partners, Inc. with participation from Takeda.

Axcelead, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Axcelead, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Axcelead, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Employee Range19
Year Founded2020
Last FundingApr 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.